WEST CONSHOHOCKEN, Pa. (AP) — WEST CONSHOHOCKEN, Pa. (AP) — Madrigal Pharmaceuticals Inc. (MDGL) on Tuesday reported a loss of $42.3 million in its second quarter.
The West Conshohocken, Pennsylvania-based company said it had a loss of $1.90 per share.
The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $3.48 per share.
The biopharmaceutical company posted revenue of $212.8 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $161.2 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MDGL at https://www.zacks.com/ap/MDGL
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
